Armata terminates CFO Erin Butler, appoints Julianne Averill as CFO via Danforth Advisors

Armata Pharmaceuticals, Inc.

Erin Butler terminated May 1, 2023 in connection with planned closure of San Diego office.
Julianne Averill appointed CFO effective May 2, 2023; serves as principal financial and accounting officer.
Averill, age 38, is a senior director at Danforth Advisors with 20+ years finance leadership.
Company pays Danforth $395/hour for Averill's services; no direct compensation to Averill.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julianne Averill

Chief Financial Officer

ARMP · Armata Pharmaceuticals, Inc.

Effective: 2023-05-02
Filed: May 5, 2023, 7:59 PM ET

On May 4, 2023, the Company’s Board of Directors (the “ Board ”) appointed Julianne Averill to serve, effective as of May 2, 2023, as Chief Financial Officer of the Company and in such capacity, also serve as principal financial officer and principal accounting officer of the Company.

Departed

Erin Butler

Vice President, Finance and Administration

ARMP · Armata Pharmaceuticals, Inc.

Effective: 2023-05-01
Successor: Julianne Averill
Filed: May 5, 2023, 7:59 PM ET

On May 1, 2023 (the “ Termination Date ”), in connection with the planned closure of the Company’s San Diego, CA office, Armata Pharmaceuticals, Inc. (the “ Company ”) terminated the employment of Erin Butler, Vice President, Finance and Administration (and principal financial officer and principal accounting officer) of the Company, effective as of close of business on the Termination Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Julianne Averill was appointed as Chief Financial Officer at Armata Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On May 4, 2023, the Company’s Board of Directors (the “ Board ”) appointed Julianne Averill to serve, effective as of May 2, 2023, as Chief Financial Officer of the Company and in such capacity, also serve as principal financial officer and principal accounting officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Erin Butler was terminated as Vice President, Finance and Administration at Armata Pharmaceuticals, Inc..

Action: terminated
Role: Vice President, Finance and Administration

Exact text from the filing

On May 1, 2023 (the “ Termination Date ”), in connection with the planned closure of the Company’s San Diego, CA office, Armata Pharmaceuticals, Inc. (the “ Company ”) terminated the employment of Erin Butler, Vice President, Finance and Administration (and principal financial officer and principal accounting officer) of the Company, effective as of close of business on the Termination Date.

View on SEC.gov

Armata Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-056598

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.